438 related articles for article (PubMed ID: 33983835)
21. Transthyretin cardiac amyloidosis: an update on diagnosis and treatment.
Yamamoto H; Yokochi T
ESC Heart Fail; 2019 Dec; 6(6):1128-1139. PubMed ID: 31553132
[TBL] [Abstract][Full Text] [Related]
22. Cardiac amyloidosis: An underdiagnosed/underappreciated disease.
Manolis AS; Manolis AA; Manolis TA; Melita H
Eur J Intern Med; 2019 Sep; 67():1-13. PubMed ID: 31375251
[TBL] [Abstract][Full Text] [Related]
23. Understanding and recognizing cardiac amyloidosis.
McVeigh T; Tennyson C
JAAPA; 2020 Oct; 33(10):16-20. PubMed ID: 32941304
[TBL] [Abstract][Full Text] [Related]
24. Transthyretin amyloidosis: an under-recognized neuropathy and cardiomyopathy.
Galant NJ; Westermark P; Higaki JN; Chakrabartty A
Clin Sci (Lond); 2017 Mar; 131(5):395-409. PubMed ID: 28213611
[TBL] [Abstract][Full Text] [Related]
25. A review of transthyretin cardiac amyloidosis.
Jhawar N; Moreno JCL; Chirila R
Rom J Intern Med; 2023 Mar; 61(1):28-34. PubMed ID: 36278951
[TBL] [Abstract][Full Text] [Related]
26. Cardiac Care of Patients with Cardiac Amyloidosis.
Itzhaki Ben Zadok O; Kornowski R
Acta Haematol; 2020; 143(4):343-351. PubMed ID: 32408301
[TBL] [Abstract][Full Text] [Related]
27. Epidemiology and clinical manifestations of cardiac amyloidosis.
Bajwa F; O'Connor R; Ananthasubramaniam K
Heart Fail Rev; 2022 Sep; 27(5):1471-1484. PubMed ID: 34694575
[TBL] [Abstract][Full Text] [Related]
28. The Ultrastructure of Tissue Damage by Amyloid Fibrils.
Koike H; Katsuno M
Molecules; 2021 Jul; 26(15):. PubMed ID: 34361762
[TBL] [Abstract][Full Text] [Related]
29. Tafamidis: a selective transthyretin stabilizer to treat wild-type ATTR amyloidosis and hereditary ATTR amyloidosis with cardiomyopathy.
Paton DM
Drugs Today (Barc); 2019 Dec; 55(12):727-734. PubMed ID: 31942875
[TBL] [Abstract][Full Text] [Related]
30. Advances in Diagnosis and Treatment of Cardiac and Renal Amyloidosis.
Law S; Fontana M; Gillmore JD
Cardiol Clin; 2021 Aug; 39(3):389-402. PubMed ID: 34247752
[TBL] [Abstract][Full Text] [Related]
31. Screening for Transthyretin Amyloid Cardiomyopathy in Everyday Practice.
Witteles RM; Bokhari S; Damy T; Elliott PM; Falk RH; Fine NM; Gospodinova M; Obici L; Rapezzi C; Garcia-Pavia P
JACC Heart Fail; 2019 Aug; 7(8):709-716. PubMed ID: 31302046
[TBL] [Abstract][Full Text] [Related]
32. Cardiac amyloidosis: a practical approach to diagnosis and management.
Kapoor P; Thenappan T; Singh E; Kumar S; Greipp PR
Am J Med; 2011 Nov; 124(11):1006-15. PubMed ID: 22017778
[TBL] [Abstract][Full Text] [Related]
33. Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments.
Sekijima Y
J Neurol Neurosurg Psychiatry; 2015 Sep; 86(9):1036-43. PubMed ID: 25604431
[TBL] [Abstract][Full Text] [Related]
34. Transthyretin Cardiac Amyloidosis: An Evolution in Diagnosis and Management of an "Old" Disease.
Smiley DA; Rodriguez CM; Maurer MS
Cardiol Clin; 2022 Nov; 40(4):541-558. PubMed ID: 36210137
[TBL] [Abstract][Full Text] [Related]
35. The diagnostic challenges of cardiac amyloidosis: A practical approach to the two main types.
Varga C; Dorbala S; Lousada I; Polydefkis MJ; Wechalekar A; Maurer MS; Comenzo RL
Blood Rev; 2021 Jan; 45():100720. PubMed ID: 32616304
[TBL] [Abstract][Full Text] [Related]
36. [Diagnosis and treatment of cardiac transthyretin amyloidosis. Innovative therapy with tafamidis.].
Legrand D; Nyssen A; Jackers L; Brogneaux C; Pirotte I; Grayet D; Lacremans D; Magnée M
Rev Med Liege; 2022 Jan; 77(1):63-68. PubMed ID: 35029343
[TBL] [Abstract][Full Text] [Related]
37. Canadian Cardiovascular Society/Canadian Heart Failure Society Joint Position Statement on the Evaluation and Management of Patients With Cardiac Amyloidosis.
Fine NM; Davis MK; Anderson K; Delgado DH; Giraldeau G; Kitchlu A; Massie R; Narayan J; Swiggum E; Venner CP; Ducharme A; Galant NJ; Hahn C; Howlett JG; Mielniczuk L; Parent MC; Reece D; Royal V; Toma M; Virani SA; Zieroth S
Can J Cardiol; 2020 Mar; 36(3):322-334. PubMed ID: 32145862
[TBL] [Abstract][Full Text] [Related]
38. Histological Typing in Patients With Cardiac Amyloidosis: JACC Review Topic of the Week.
Gonzalez-Lopez E; McPhail ED; Salas-Anton C; Dominguez F; Gertz MA; Dispenzieri A; Dasari S; Milani P; Verga L; Grogan M; Palladini G; Garcia-Pavia P
J Am Coll Cardiol; 2024 Mar; 83(11):1085-1099. PubMed ID: 38479957
[TBL] [Abstract][Full Text] [Related]
39. Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis.
Maurer MS; Bokhari S; Damy T; Dorbala S; Drachman BM; Fontana M; Grogan M; Kristen AV; Lousada I; Nativi-Nicolau J; Cristina Quarta C; Rapezzi C; Ruberg FL; Witteles R; Merlini G
Circ Heart Fail; 2019 Sep; 12(9):e006075. PubMed ID: 31480867
[TBL] [Abstract][Full Text] [Related]
40. Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association.
Kittleson MM; Maurer MS; Ambardekar AV; Bullock-Palmer RP; Chang PP; Eisen HJ; Nair AP; Nativi-Nicolau J; Ruberg FL;
Circulation; 2020 Jul; 142(1):e7-e22. PubMed ID: 32476490
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]